Market Tracker

07/29 7:53am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.57
Delayed Data
As of Jul 28
 +0.01 / +0.64%
Today’s Change
1.08
Today|||52-Week Range
3.33
-4.27%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.56
Today’s open1.59
Day’s range1.49 - 1.60
Volume48,604
Average volume (3 months)109,785
Market cap$45.2M
Dividend yield--
Data as of 07/28/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)-12.12%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.03-1.35%
TROVUTrovagene Inc0.000.00%
TTHITransition Therapeut...-0.02-1.26%
INISInternational Isotop...0.000.00%
Data as of 07/28/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts